This PDF is available from The National Academies Press at http://www.nap.edu/catalog.php?record_id=21767 Non-Invasive Neuromodulation of the Central Nervous System: Opportunities and Challenges: Workshop Summary ISBN Lisa Bain, Sheena Posey Norris, and Clare Stroud, Rapporteurs; Forum on 978-0-309-37618-1 Neuroscience and Nervous System Disorders; Board on Health Sciences Policy; Institute of Medicine; The National Academies of Sciences, 118 pages Engineering, and Medicine 6 x 9 PAPERBACK (2015) Visit the National Academies Press online and register for... Instant access to free PDF downloads of titles from the NATIONAL ACADEMY OF SCIENCES NATIONAL ACADEMY OF ENGINEERING INSTITUTE OF MEDICINE NATIONAL RESEARCH COUNCIL 10% off print titles Custom notification of new releases in your field of interest Special offers and discounts Distribution, posting, or copying of this PDF is strictly prohibited without written permission of the National Academies Press. Unless otherwise indicated, all materials in this PDF are copyrighted by the National Academy of Sciences. Request reprint permission for this book Copyright © National Academy of Sciences. All rights reserved. Non-Invasive Neuromodulation of the Central Nervous System: Opportunities and Challenges: Workshop Summary NON-INVASIVE NEUROMODULATION OF THE CENTRAL NERVOUS SYSTEM Opportunities and Challenges WORKSHOP SUMMARY Lisa Bain, Sheena Posey Norris, and Clare Stroud, Rapporteurs Forum on Neuroscience and Nervous System Disorders Board on Health Sciences Policy Institute of Medicine PREPUBLICATION COPY: UNCORRECTED PROOFS Copyright © National Academy of Sciences. All rights reserved. Non-Invasive Neuromodulation of the Central Nervous System: Opportunities and Challenges: Workshop Summary THE NATIONAL ACADEMIES PRESS • 500 Fifth Street, NW • Washington, DC 20001 This project was supported by contracts between the National Academy of Sci- ences and the Alzheimer’s Association; Brain Canada Foundation; the Depart- ment of Health and Human Services’ Food and Drug Administration and National Institutes of Health (NIH, Contract No. HHSN26300026 [Under Mas- ter Base #DHHS-10001292]) through the National Center for Complementary and Integrative Health, National Eye Institute, National Institute of Mental Health, National Institute of Neurological Disorders and Stroke, National Insti- tute on Aging, National Institute on Alcohol Abuse and Alcoholism, National Institute on Drug Abuse, and NIH Blueprint for Neuroscience Research; De- partment of Veterans Affairs (VA240-14-C-0057); Eli Lilly and Company; Foundation for the National Institutes of Health; the Gatsby Charitable Founda- tion; GlaxoSmithKline, Inc.; Johnson & Johnson Pharmaceutical Research and Development, LLC; Lundbeck Research USA; Merck Research Laboratories; The Michael J. Fox Foundation for Parkinson’s Research; the National Multiple Sclerosis Society; the National Science Foundation (BCS-1064270); One Mind for Research; Orion Bionetworks; Pfizer Inc.; Pharmaceutical Product Devel- opment, LLC; Sanofi; the Society for Neuroscience; Takeda Pharmaceutical Company Limited; and Wellcome Trust. The views presented in this publication do not necessarily reflect the views of the organizations or agencies that provid- ed support for this project. International Standard Book Number-13: XXX International Standard Book Number-10: XXX Additional copies of this report are available from the National Academies Press, 500 Fifth Street, NW, Keck 360, Washington, DC 20001; (800) 624-6242 or (202) 334-3313; http://www.nap.edu. Copyright 2015 by the National Academy of Sciences. All rights reserved. Printed in the United States of America Suggested citation: National Academies of Sciences, Engineering, and Medi- cine. 2015. Non-invasive neuromodulation of the central nervous system: Op- portunities and challenges: Workshop summary. Washington, DC: The National Academies Press. PREPUBLICATION COPY: UNCORRECTED PROOFS Copyright © National Academy of Sciences. All rights reserved. Non-Invasive Neuromodulation of the Central Nervous System: Opportunities and Challenges: Workshop Summary The National Academy of Sciences was established in 1863 by an Act of Congress, signed by President Lincoln, as a private, nongovernmental institution to advise the nation on issues related to science and technology. Members are elected by their peers for outstanding contributions to research. Dr. Ralph J. Cicerone is president. The National Academy of Engineering was established in 1964 under the charter of the National Academmy of Sciences to bring the practices of engineering to advising tthe nation. Members are elected by their peers for extraordinary contributions to engi- neering. Dr. C. D. Mote, Jr., is president. The National Academy of Medicine (formmerly the Institute of Medicine) was established in 1970 underr the charter of the Na- tional Academy of Sciences to advise the nation on medical and health issues. Members are elected by their peers for distin- guished contributions to medicine and health. Dr. Victor J. Dzau is president. The three Academies work together as thhe Nationall Academies of Sciences, Engineering, and Medicine to provide independ- ent, objective analysis and advice to the nation and conduct other activities to solve complex problems and inform public pol- icy decisions. The Academies also encourage education and re- search, recognize outstanding contributiions to knowledge, and increase public understanding in matters of science, engineering, and medicine. Learn more about the National Academies of Sciencees, Engineer- ing, and Medicine at www.national-academies.org. PREPUBLICATION COPY: UNCORRECTED PROOFS Copyright © National Academy of Sciences. All rights reserved. Non-Invasive Neuromodulation of the Central Nervous System: Opportunities and Challenges: Workshop Summary Copyright © National Academy of Sciences. All rights reserved. Non-Invasive Neuromodulation of the Central Nervous System: Opportunities and Challenges: Workshop Summary PLANNING COMMITTEE ON NON-INVASIVE NEUROMODULATION OF THE CENTRAL NERVOUS SYSTEM1 HANK GREELY (Co-Chair), Stanford University JEFFREY NYE (Co-Chair), Johnson & Johnson Innovation ALVARO PASCUAL-LEONE (Co-Chair), Harvard Medical School STEPHEN BRANNAN, Takeda Pharmaceuticals International, Inc. MARTHA FARAH, University of Pennsylvania TOM INSEL, National Institute of Mental Health DANIEL JAVITT, Columbia University FRANCES JENSEN, University of Pennsylvania WALTER KOROSHETZ, National Institute of Neurological Disorders and Stroke JAY KRANZLER, Pfizer, Inc. VICTOR KRAUTHAMER, Food and Drug Administration ANNE LOUISE OAKLANDER, Massachusetts General Hospital CARLOS PEÑA, Food and Drug Administration PETER REINER, University of British Columbia RHONDA ROBINSON-BEALE, Blue Cross of Idaho JUSTIN SANCHEZ, Defense Advanced Research Projects Agency ROGER SORENSON, National Institute on Drug Abuse IOM Staff CLARE STROUD, Project Director SHEENA M. POSEY NORRIS, Associate Program Officer SOPHIE YANG, Senior Program Assistant ANDREW M. POPE, Director, Board on Health Sciences Policy 1Institute of Medicine planning committees are solely responsible for organizing the workshop, identifying topics, and choosing speakers. The responsibility for the published workshop summary rests with the workshop rapporteurs and the institution. v PREPUBLICATION COPY: UNCORRECTED PROOFS Copyright © National Academy of Sciences. All rights reserved. Non-Invasive Neuromodulation of the Central Nervous System: Opportunities and Challenges: Workshop Summary Copyright © National Academy of Sciences. All rights reserved. Non-Invasive Neuromodulation of the Central Nervous System: Opportunities and Challenges: Workshop Summary FORUM ON NEUROSCIENCE AND NERVOUS SYSTEM DISORDERS1 STEVEN HYMAN (Chair), The Broad Institute of Massachusetts Institute of Technology and Harvard University STORY LANDIS (Vice Chair), Former Director, National Institute of Neurological Disorders and Stroke SUSAN AMARA, Society for Neuroscience STEPHEN BRANNAN, Takeda Pharmaceuticals International, Inc. KATJA BROSE, Cell Press DANIEL BURCH, Pharmaceutical Product Development, LLC SARAH CADDICK, Gatsby Charitable Foundation ROSA CANET-AVILES, Foundation for the National Institutes of Health MARIA CARRILLO, Alzheimer’s Association C. THOMAS CASKEY, Baylor College of Medicine KAREN CHANDROSS, Sanofi US TIMOTHY COETZEE, National Multiple Sclerosis Society FAY LOMAX COOK, National Science Foundation WILLIAM DUNN, Food and Drug Administration EMMELINE EDWARDS, National Center for Complementary and Integrative Health MARTHA FARAH, University of Pennsylvania DANIEL GESCHWIND, University of California, Los Angeles HANK GREELY, Stanford University MAGALI HAAS, Orion Bionetworks RAMONA HICKS, One Mind for Research RICHARD HODES, National Institute on Aging STUART HOFFMAN, U.S. Department of Veterans Affairs THOMAS INSEL, National Institute of Mental Health PHILIP IREDALE, Pfizer Global Research and Development JOHN ISAAC, Wellcome Trust INEZ JABALPURWALA, Brain Canada Foundation FRANCES JENSEN, University of Pennsylvania School of Medicine GEORGE KOOB, National Institute on Alcohol Abuse and Alcoholism 1Institute of Medicine forums and roundtables do not issue, review, or approve individual documents. The responsibility for the published workshop summary rests with the workshop rapporteurs and the institution. vii PREPUBLICATION COPY: UNCORRECTED PROOFS Copyright © National Academy of Sciences. All rights reserved. Non-Invasive Neuromodulation of the Central